Shire Human Genetic Therapies, Inc. 3
3 · Translate Bio, Inc. · Filed Jun 27, 2018
Insider Transaction Report
Form 3
Shire Human Genetic Therapies, Inc.
10% Owner
Holdings
- 6,895,325
Common Stock
Footnotes (1)
- [F1]These shares are owned directly by Shire Human Genetic Therapies, Inc., which is an indirect wholly owned subsidiary of Shire plc. Shire plc is an indirect beneficial owner of the reported securities.